Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes "CRESCENDO"

Terminated

Phase 3 Results N/A

References

Publications

  • Topol EJ, Bousser MG, Fox KA, Creager MA, Despres JP, Easton JD, Hamm CW, Montalescot G, Steg PG, Pearson TA, Cohen E, Gaudin C, Job B, Murphy JH, Bhatt DL; CRESCENDO Investigators. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet. 2010 Aug 14;376(9740):517-23. doi: 10.1016/S0140-6736(10)60935-X. Pubmed ID:20709233

Sources for Trial Information